Afatinib Gilotrif is an initial treatment option for NSCLC. It is a type of druged a tyrosine kinase inhibitor TKI . Erlotinib Tarceva has been shown to work better than chemotherapy if the lung cancer has a mutation in the EGFR gene. It is an option for patients with lo.y advanced and metastatic NSCLC..
Related posts to New Drug For Lung Cancer
FRIDAY, July HealthDay News A new drug to treat advanced lung cancer has been approved by the U.S. Food and Drug Administration. Gilotrif is .
A new cancer drug, Opdivo, is working so well that pharmaceutical giant Bristol Myers Squibb announced Monday it is stopping a trial in lung cancer two .
TGA approves new lung cancer drug osimertinib for patients dealt cruel double blow.
SUNDAY, Sept. , HealthDay News A new study finds that the cancer drug nivolumab Opdivo extends the lives of some patients with advanced lung .